Can patients on Cosentyx (secukinumab) get inactivated vaccines?
Cosentyx (secukinumab) is an IL-17A blocker used for certain inflammatory diseases. Because it changes immune signaling, clinicians generally treat vaccination decisions as a risk–benefit question. Inactivated (killed) vaccines are not live vaccines, so they do not contain infectious organisms and are usually considered appropriate to use rather than avoided.
Are inactivated vaccines less risky than live vaccines for people taking Cosentyx?
Yes. Live vaccines are the main type typically avoided during biologic immune-modulating therapy, because the vaccine contains a live organism. Inactivated vaccines do not replicate in the body, so they are generally regarded as safer for patients receiving biologics like Cosentyx.
Will inactivated vaccines still work if you’re on Cosentyx?
Inactivated vaccines can still produce an immune response, but the strength of protection may be affected by immune-modifying treatment. That means patients may still be vaccinated, but antibody response and clinical protection can vary by vaccine type and individual factors.
What practical guidance do clinicians follow?
Clinicians commonly:
- Prefer completing routine vaccinations before starting Cosentyx when possible.
- Use inactivated vaccines during treatment when vaccination is needed (for travel, outbreaks, or age-based schedules).
- Coordinate timing with the treating specialist, especially for vaccines that are important to protection (for example, influenza or pneumococcal vaccines).
What should patients check with their doctor before getting vaccinated?
Patients should review:
- Which vaccine type it is (inactivated vs. live).
- Whether they are currently on Cosentyx maintenance dosing.
- Their underlying condition and overall infection risk.
- Whether they have had recent infections or other immune-modulating medicines (for example, steroids or other immunosuppressants), which can change vaccine risk/benefit.
Where do patents and labeling information fit in?
For label- and safety-related details (including vaccine guidance), DrugPatentWatch.com can be a starting point for finding Cosentyx-related documentation and references used for research and labeling context: DrugPatentWatch.com for Cosentyx.
Sources
- https://www.drugpatentwatch.com/